-
Je něco špatně v tomto záznamu ?
A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery
D. Enikeev, O. Traxer, M. Taratkin, Z. Okhunov, S. Shariat
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, systematický přehled
- MeSH
- endoskopie MeSH
- karcinom z renálních buněk chirurgie MeSH
- laserová litotripse * MeSH
- lasery pevnolátkové * terapeutické užití MeSH
- lidé MeSH
- nádory měkkých tkání chirurgie MeSH
- nemoci prostaty chirurgie MeSH
- thulium terapeutické užití MeSH
- urolitiáza chirurgie MeSH
- urologické nádory chirurgie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- systematický přehled MeSH
PURPOSE OF REVIEW: To evaluate emerging evidence and practical applications of thulium-fiber laser (TFL) for genitourinary soft tissue disease and urinary stone disease treatment. RECENT FINDINGS: A systematic review was developed using the PubMed, ScienceDirect, Wiley, SpringerLink and Mary Ann Liebert Scopus databases between 2012 and 2020 years, using the PRISMA statement. We analyzed recent publications including in vitro and in humans outcomes of surgery using TFL. This new laser technology can be used in soft tissue diseases and stones present in the genitourinary system. Most of the comparisons are made with the Ho:YAG laser, using completely different settings. Nevertheless, TFL is safe, feasible and effective in the management of urologic diseases, showing superiority to Ho:YAG even in some studies. SUMMARY: The introduction of pulsed TFL technology has enabled the ablation of stones at rates comparable to or better than currently existing lasers in vitro, while also potentially reducing stone retropulsion. TFL is effective in treating genitourinary soft tissue diseases, including benign prostatic hyperplasia, and early data indicate that it may be effective in the treatment of urinary stone disease. More clinical studies are needed to better understand the indications for this novel technology and clarify its position in the urologic endoscopy armamentarium.
Department of Urology 2nd Faculty of Medicine Charles University Prag Czech Republic
Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria
Department of Urology University of California Irvine California USA
Department of Urology University of Texas Southwestern Dallas Texas USA
Department of Urology Weill Cornell Medical College New York New York
GRC 20 Lithiase Urinaire Sorbonne University Hôpital Tenon Paris France
Institute for Urology and Reproductive Health Sechenov University Moscow Russia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019869
- 003
- CZ-PrNML
- 005
- 20210830101452.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MOU.0000000000000815 $2 doi
- 035 __
- $a (PubMed)32925311
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Enikeev, Dmitry $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
- 245 12
- $a A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery / $c D. Enikeev, O. Traxer, M. Taratkin, Z. Okhunov, S. Shariat
- 520 9_
- $a PURPOSE OF REVIEW: To evaluate emerging evidence and practical applications of thulium-fiber laser (TFL) for genitourinary soft tissue disease and urinary stone disease treatment. RECENT FINDINGS: A systematic review was developed using the PubMed, ScienceDirect, Wiley, SpringerLink and Mary Ann Liebert Scopus databases between 2012 and 2020 years, using the PRISMA statement. We analyzed recent publications including in vitro and in humans outcomes of surgery using TFL. This new laser technology can be used in soft tissue diseases and stones present in the genitourinary system. Most of the comparisons are made with the Ho:YAG laser, using completely different settings. Nevertheless, TFL is safe, feasible and effective in the management of urologic diseases, showing superiority to Ho:YAG even in some studies. SUMMARY: The introduction of pulsed TFL technology has enabled the ablation of stones at rates comparable to or better than currently existing lasers in vitro, while also potentially reducing stone retropulsion. TFL is effective in treating genitourinary soft tissue diseases, including benign prostatic hyperplasia, and early data indicate that it may be effective in the treatment of urinary stone disease. More clinical studies are needed to better understand the indications for this novel technology and clarify its position in the urologic endoscopy armamentarium.
- 650 _2
- $a karcinom z renálních buněk $x chirurgie $7 D002292
- 650 _2
- $a endoskopie $7 D004724
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a lasery pevnolátkové $x terapeutické užití $7 D053844
- 650 12
- $a laserová litotripse $7 D017602
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nemoci prostaty $x chirurgie $7 D011469
- 650 _2
- $a nádory měkkých tkání $x chirurgie $7 D012983
- 650 _2
- $a thulium $x terapeutické užití $7 D013932
- 650 _2
- $a urolitiáza $x chirurgie $7 D052878
- 650 _2
- $a urologické nádory $x chirurgie $7 D014571
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a systematický přehled $7 D000078182
- 700 1_
- $a Traxer, Olivier $u GRC #20 Lithiase Urinaire, Sorbonne University, Hôpital Tenon, Paris, France
- 700 1_
- $a Taratkin, Mark $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
- 700 1_
- $a Okhunov, Zhamshid $u Department of Urology, University of California, Irvine, California, USA
- 700 1_
- $a Shariat, Shahrokh $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, Weill Cornell Medical College, New York, New York $u Department of Urology, University of Texas Southwestern, Dallas, Texas, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic $u Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan
- 773 0_
- $w MED00001296 $t Current opinion in urology $x 1473-6586 $g Roč. 30, č. 6 (2020), s. 853-860
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32925311 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101452 $b ABA008
- 999 __
- $a ok $b bmc $g 1690634 $s 1140315
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 30 $c 6 $d 853-860 $e - $i 1473-6586 $m Current opinion in urology $n Curr Opin Urol $x MED00001296
- LZP __
- $a Pubmed-20210728